Ryan Zimmerman

Intuitive Surgical Inc (NASDAQ:ISRG) reported its fourth-quarter results in line with its preannouncement and announced a "measured" guidance for 2026, according to BTIG. The Intuitive Surgical Analyst: Analyst Ryan Zimmerman reiterated a Buy rating and price target of $616. The Intuitive Surgical...

Shares of Medtronic PLC (NYSE:MDT) inched higher in early trading on Wednesday, as the company on Tuesday reported strong fiscal second-quarter results. MDT is approaching key resistance levels. Follow the breaking news here. Here are some key analyst takeaways: Needham analyst Mike Matson...

Globus Medical Inc’s (NYSE: GMED) shares have declined around 33% from their year-end 2019 high, and the company has a strong balance sheet that can be used to acquire assets at depressed values, according to BTIG. The Globus Medical Analyst BTIG’s Ryan Zimmerman upgraded...

Orthofix Medical Inc (NASDAQ: OFIX) reported quarterly results Monday that were broadly in-line with expectations while guiding to higher spending and linear revenue growth. Investors can look past the guidance and the announcement of CEO Brad Mason's retirement during a...

Endologix, Inc. (NASDAQ: ELGX) announced on Thursday after the market close that it needs to conduct a confirmatory clinical trial for its Nellix Endovascular Aneurysm Sealing System with the previously updated instructions for use and the Gen2 device design. This follows the company's meeting...